Condensed Statements of Operations and Comprehensive Loss - USD ($)
3 Months Ended 9 Months Ended
Sep. 30, 2019
Sep. 30, 2018
Sep. 30, 2019
Sep. 30, 2018
Operating expenses:        
Research and development $ 3,943,420 $ (1,785,645) $ 8,215,079 $ 5,815,580
General and administrative 2,564,508 1,565,992 8,728,714 8,669,455
Total operating expenses, net 6,507,928 (219,653) 16,943,793 14,485,035
Income (loss) from operations (6,507,928) 219,653 (16,943,793) (14,485,035)
Other income (expense):        
Interest income 57,848 42,431 156,945 127,560
Interest expense (472,052) (1,038,014) (1,330,923) (5,593,751)
Loss on extinguishment of convertible note payable 0 0 (1,049,166) 0
Change in fair value of derivative liability and extinguishment of derivative liability 229,000 0 881,000 0
Change in fair value of warrant liabilities (2,528,100) 0 141,700 0
Total other income (expense), net (2,713,304) (995,583) (1,200,444) (5,466,191)
Loss before income taxes (9,221,232) (775,930) (18,144,237) (19,951,226)
Benefit from income taxes 0 0 0 0
Net loss $ (9,221,232) $ (775,930) $ (18,144,237) $ (19,951,226)
Net loss per common share, basic and diluted (in usd per share) $ (0.26) $ (0.03) $ (0.56) $ (0.82)
Weighted-average common shares, basic and diluted (in shares) 35,883,953 25,818,495 32,401,624 24,269,266